Founded in 1997, High Throughput Genomics Inc. is a provider of the quantitative Nuclease Protection Assay (NPA) technology for medical research purpose. Based in Tucson, Ariz., the company s technology is used to carry out quantitative, multiplexed gene-based drug discovery programs, including target evaluation; HTS lead optimization, metabolism and toxicology. It has expanded into the fields of gene expression profiling, translational medicine and diagnostic applications and measurement of miRNA. Investors in the company include Solstice Capital, Valley Ventures, Merck Capital Ventures, Village Ventures and Arcturus Capital. Its other products comprise qNPA ArrayPlate and qNPA Microarray.
Categories
Air Conditioning Contractors & SystemsHeating Contractors & Specialties